Literature DB >> 5302303

Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.

A S Benenson, A Saad, W H Mosley.   

Abstract

A microtechnique is described for the determination of vibriocidal antibodies to Vibrio cholerae, using 0.025 ml of fingertip blood or venous serum per test. This test could be used in epidemiological surveys, or as a routine test on patients admitted to hospital.Fourfold or greater rises in vibriocidal titre were noted for 96.5% of 370 bacteriologically confirmed cholera patients in an endemic area of East Pakistan (91.5% for the 94 children under 5 years in the study group). It is necessary to test sera against both Ogawa and Inaba serotypes of V. cholerae, as a significant titre rise was found against the homologous serotype only in 11% of the cases, and against the heterologous serotype only in 2%.Six serologically positive but bacteriologically negative persons were found to be household contacts of confirmed cholera patients (and 3 of the contacts had been vaccinated against cholera within 1 week before testing); 3 other cases (1.6%) were considered to be false positives.The vibriocidal test using fingertip blood was compared with daily rectal swabbing for the detection of cholera carriers among 153 household contacts of cholera patients, who had not received cholera vaccine within 2 weeks before testing; 16% gave a positive vibriocidal titre, while V. cholerae was isolated from 13% only.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5302303      PMCID: PMC2554323     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  PASSIVE SERUM PROTECTION OF THE INFANT RABBIT AGAINST EXPERIMENTAL CHOLERA.

Authors:  O R MCINTYRE; J C FEELEY
Journal:  J Infect Dis       Date:  1964-12       Impact factor: 5.226

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  Preparation of formalinized erythrocytes.

Authors:  L CSIZMAS
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

4.  Quantitative studies on the bactericidal actions of serum and complement. I. A rapid photometric growth assay for bactericidal activity.

Authors:  L H MUSCHEL; H P TREFFERS
Journal:  J Immunol       Date:  1956-01       Impact factor: 5.422

5.  Vibriocidal and agglutinating antibody patterns in cholera patients.

Authors:  R B Sack; D Barua; R Saxena; C C Carpenter
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

6.  Serological studies in cholera. I. Vibrio agglutinin response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; M Paul
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  6 in total
  49 in total

1.  Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.

Authors:  S J Cryz; M M Levine; G Losonsky; J B Kaper; B Althaus
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher response.

Authors:  T Ramamurthy; Diane Wagener; Goutam Chowdhury; Partha P Majumder
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

4.  Type-specific action of vibriocidal antibody on Vibrio cholerae.

Authors:  A H Pykett; N W Preston
Journal:  J Hyg (Lond)       Date:  1975-12

5.  Serotype cycles in cholera dynamics.

Authors:  Katia Koelle; Mercedes Pascual; Md Yunus
Journal:  Proc Biol Sci       Date:  2006-11-22       Impact factor: 5.349

6.  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.

Authors:  Wilbur H Chen; Richard N Greenberg; Marcela F Pasetti; Sofie Livio; Michael Lock; Marc Gurwith; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

7.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

8.  Genomic correlates of variability in immune response to an oral cholera vaccine.

Authors:  Partha P Majumder; Neeta Sarkar-Roy; Herman Staats; T Ramamurthy; Sujit Maiti; Goutam Chowdhury; Carol C Whisnant; K Narayanasamy; Diane K Wagener
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

9.  Evaluation of the card test for diagnosis of human brucellosis.

Authors:  A O Russell; C M Patton; A F Kaufmann
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

10.  Immunity to Vibrio cholerae in the mouse. II. Effect of a cell-adherent immune factor.

Authors:  P Actor; D Pitkin
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.